Overview

FDGal PET/CT to Detect Hepatocellular Carcinoma

Status:
Withdrawn
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
Liver cancer is one of the leading causes of cancer death among Asian men. If diagnosed early the disease is treatable with surgery. Current conventional imaging modalities have limitations to early detection. This study proposes to use 18F-FGal and 18F-FDG PET/CT scans to compare the clinical efficacy of diagnosing hepatocellular carcinoma (a type of liver cancer) using these PET/CT scans.
Details
Lead Sponsor:
British Columbia Cancer Agency
Treatments:
Fluorodeoxyglucose F18